The company's focus is on improving clinical outcomes for patients with opioid use disorder, viral respiratory infections, and other painful inflammation and toxin-induced conditions. They develop consumer healthcare products that mitigate common side effects from medicines and everyday living. Sen-Jam's global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Their drugs stabilize the immune system, helping the patient's body to maintain homeostasis, encounter flu vaccines, opioid withdrawal, common cold, and hangover side-effects, improving the lives of patients. Sen-Jam Pharmaceutical is on a mission to help people live side-effect free and create a stronger, more resilient world.